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Abstract
Post-concussion syndrome (PCS) refers to a constellation of physical, cognitive, and emotional symptoms after
traumatic brain injury (TBI). Despite its incidence and impact, the underlying mechanisms of PCS are unclear. We
hypothesized that impaired cerebral autoregulation (CA) is a contributor. In this article, we present our protocol
for non-invasively assessing CA in patients with TBI and PCS in a real-world clinical setting. A prospective, obser-
vational study was integrated into outpatient clinics at a tertiary neurosurgical center. Data points included: de-
mographics, symptom profile (Post-Concussion Symptom Scale [PCSS]) and neuropsychological assessment
(Cambridge Neuropsychological Test Automated-Battery [CANTAB]). Cerebrovascular metrics (nMxa co-efficient
and the transient hyperaemic-response ratio [THRR]) were collected using transcranial Doppler (TCD), finger
plethysmography, and bespoke software (ICM+). Twelve participants were initially recruited but 2 were excluded
after unsuccessful insonation of the middle cerebral artery (MCA); 10 participants (5 patients with TBI, 5 healthy
controls) were included in the analysis (median age 26.5 years, male to female ratio: 7:3). Median PCSS scores
were 6/126 for the TBI patient sub-groups. Median CANTAB percentiles were 78 (healthy controls) and 25
(TBI). nMxa was calculated for 90% of included patients, whereas THRR was calculated for 50%. Median study
time was 127.5 min and feedback (n = 6) highlighted the perceived acceptability of the study. This pilot study
has demonstrated a reproducible assessment of PCS and CA metrics (non-invasively) in a real-world setting.
This protocol is feasible and is acceptable to participants. By scaling this methodology, we hope to test whether
CA changes are correlated with symptomatic PCS in patients post-TBI.
Keywords: brain concussion; cerebral blood flow; cerebrovascular circulation; post-concussion syndrome;
traumatic brain injury
Introduction
Traumatic brain injury (TBI) is a global challenge. An
estimated 50 million cases of TBI occur yearly world-
wide resulting in significant mortality, morbidity, and
global economic expense ($US400 billion per year).1,2
Mild TBI (mTBI), commonly defined by a Glasgow
Coma Scale (GCS) score between 13 and 15, represents
90% of TBI cases.3 Post-concussion syndrome (PCS)
refers to a constellation of physical, cognitive, emo-
tional, and psychiatric symptoms including headache,
1Division of Neurosurgery, 5Department of ENT, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
2Brain Physics Laboratory, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.
3Department of Biomedical Engineering, Faculty of Fundamental Problems of Technology, Wroclaw University of Science and Technology, Wroclaw, Poland.
4Department of Neurorehabilitation, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
6Institute of Electronic Systems, Warsaw University of Technology, Warsaw, Poland.
*Address correspondence to: Danyal Z. Khan, MRCS, Division of Neurosurgery, University of Cambridge and Cambridge University Hospitals NHS Foundation Trust,
Cambridge CB20QQ, United Kingdom, E-mail: danyal.khan@nhs.net
ª Danyal Z. Khan et al., 2020; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons
License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the





difficulty concentrating, memory problems, depres-
sion, and anxiety.4 PCS is most often described in
the setting of TBI, most commonly after mTBI.5 Its
prevalence post-TBI is between 11 and 82%,6 with a
highly variable clinical course.6 Indeed, PCS contrib-
utes to a considerable amount of the economic burden
(due to medical costs and loss of working time/
performance) after TBI. Its morbidity is pervasive,
negatively impacting patients’ quality of life across
multiple domains.2,5,7
Despite the incidence and impact of PCS after
mTBI, it is a poorly characterized entity owing to het-
erogeneity in definitions, diagnostic criteria, and pa-
tient populations.6 Similarly, uncertainty and debate
exist regarding the underlying mechanisms of PCS,
particularly persistent variants of the syndrome.5,8
Additionally, there appears to be a degree of overlap
between non-vestibular dizziness and PCS syn-
dromes—with both describing non-specific dizziness,
often exacerbated by anxiety and hyperventilation.9
Non-vestibular dizziness, also known as chronic sub-
jective dizziness or persistent postural-perceptual diz-
ziness (PPPD), may or may not be preceded by TBI or
other vestibular pathology.10 Post-traumatic dizziness
is disabling—being an independent adverse prognos-
tic indicator post-TBI.11 It proves difficult to treat
when compared with non-traumatic dizziness/verti-
go—again, related to poor understanding of underly-
ing mechanisms.12 There may be a cerebrovascular
component to the pathogenesis of several vestibular
disorders, with recent studies suggesting dynamic
links between vestibular system activation and cere-
bral blood flow (CBF).13
We hypothesized that impaired cerebral autoregula-
tion (CA) post-TBI contributes to these clinical syn-
dromes. Cerebral autoregulation refers to the
myogenic ability of the cerebral vasculature to maintain
adequate CBF over a range of arterial blood pressures
(ABPs).14 Usually, CA is able to maintain stable aver-
age CBF values between a mean ABP (MAP) range
of 50–150 mm Hg.14 On the other hand, the ability to
change CBF in response to arterial CO2 is termed cere-
brovascular reactivity (CRx).15 Consequences of CA
and CRx failure exist as a spectrum, ranging from the
extremes of chronic ischemia to hyperperfusion, and
can be globally, heterogeneously, or locally distribut-
ed.16,17 Disrupted CA and CRx have been observed in
all degrees of TBI, even when values for CBF, cerebral
perfusion pressure, ABP, and intracranial pressure
(ICP) are normal.18,19
Two complimentary (non-invasive) methodologies
have provided evidence of the link between PCS and
CA and CRx in the context of mTBI. Advanced imag-
ing techniques such as arterial spin labeling (ASL)
magnetic resonance imaging (MRI) have shown de-
rangements in CBF in the context of mTBI and PCS
symptoms.17,20 Similarly, blood oxygenation level-
dependent functional MRI has shown changes in
brain activation after concussion.21,22 However, these
modalities are expensive, not widely available, lengthy,
and not tolerated by some patients (e.g., those with
claustrophobia). Some of these disadvantages are offset
by using transcranial Doppler (TCD) as an alternative
method. Using TCD studies has corroborated the he-
modynamic disruption after concussion in real time—
highlighting CRx and CA dysfunction in patients with
mTBI with PCS symptoms.15,23–26 However, these
studies are limited by small sample sizes, lack of longi-
tudinal assessment, use of crude CA metrics, and fre-
quent assessment of CRx without CA.
TCD provides a non-invasive and inexpensive
method for repeated and robust assessment of CA.27
By calculating the correlation between changes in cere-
bral blood flow velocity (CBFV) at the middle cerebral
artery (MCA) and changes in ABP (also measured
non-invasively using finger plethysmography), a coeffi-
cient termed nMxa is derived. This has been found to
correlate well (R = 0.755) with its invasive counterpart,
Mx—a CA metric calculated using an arterial line and
an ICP monitor to derive cerebral perfusion pressure.28
An Mx/nMxa value of >0.4 is indicative of cerebrovas-
cular autoregulatory dysfunction.28 Further, Mx/nMxa
correlates with other measures of autoregulation, (e.g.,
static cerebral autoregulation [sRoR] and CO2 reactiv-
ity)29,30 and may be less influenced by signal noise
(as may be expected in alert patients with concussion)
when compared with systolic-based autoregulation
metrics. Additionally, the transient hyperaemic re-
sponse ratio (THRR) represents another reproducible,
non-invasive CA metric that correlates with TBI sever-
ity and TBI-specific outcome.31,32
We have adopted a fully non-invasive methodology
to test the hypothesis that changes in CA are correlated
with symptomatic PCS in patients with a history of
TBI. We have assessed these metrics alongside PCS
symptoms (and their impact on daily living) to assess
the feasibility of this technique in a real-world clinical
setting. In this article, we present our methodology
and pilot experience as to its feasibility and acceptabil-
ity for scaling.





A prospective, observational design was adopted, and it
was utilized at a tertiary university neurosurgical center
(Cambridge University Hospitals).
Ethical approval
The formal regional and institutional ethical board
reviewed and approved this study (ethics reference
number: 19/SC/0444). Written informed consent was
ascertained from every human participant in the
study. Patient data remains anonymized as a condition
of ethical approval. Anonymized data are available
upon request.
Population
Inclusion criteria for patients were: having a history of
TBI, with or without symptoms of PCS, presenting for
follow-up at neurotrauma outpatient clinics. Exclusion
criteria involved: age <16 years, history of pre-morbid
symptoms overlapping with PCS, severe periph-
eral vascular disease (preventing finger plethysmo-
graph use), and significant obstructive respiratory
disease. A separate control group of healthy controls
(asymptomatic patients without a TBI history) was
also included.
Suitable patients were identified from routine neuro-
trauma outpatient clinic lists. Recruitment via in-
formed consent was carried out by a research team
member independent from the clinical team. For prag-
matic and participant convenience purposes, recruit-
ment and data collection were integrated alongside
clinical assessments. Study participants had the choice
of same-day study measurements (while waiting for
their clinical appointments) or booking an alternative
time.
Data set
The measured data set covered multiple domains: de-
mographics, symptoms, neuropsychological metrics,
quality of life scores, and cerebrovascular and vestibu-
lar profiles. These domains were guided by the U.S.
National Institutes of Health’s (NIH’s) National Insti-
tute of Neurological Disorders and Stroke (NINDS)
Common Data Elements TBI with instruments within
domains adapted to local expertise in instrument avail-
ability and delivery.33 Demographics included age, sex,
medical/TBI history, cardiovascular medications,
smoking history, and alcohol history (Supplementary
Fig. S1). Symptom questionnaires included a 21-item
Post-Concussion Symptom Scale34 (PCSS), a 9-point
Vestibular Visual Analogue Scale (VVAS),35 and a be-
spoke vestibular symptom checklist aimed at character-
izing dizziness episodes (if present; Supplementary
Fig. S1).
The neuropsychological and cognitive assessment
consisted of the Cambridge Neuropsychological Test
Automated Battery (CANTAB): TBI battery.36 Quality
of life and extended outcomes aiming to capture the
wider context involved completion of the Glasgow
Outcome Scale Extended (GOS-E)37 and the standard
Short Form 36 Health Survey (SF-36).38,39 Cerebrovas-
cular metrics were collected using an integrated TCD,
finger plethysmograph, and bespoke software to calcu-
late nMxa and THRR, as described below. The vestib-
ular assessment involved assessing nystagmus at rest,
a horizontal head impulse test, and a Fukuda stepping
test (marked as normal, mildly abnormal, or strongly
abnormal). The primary outcomes for the study were
the calculation of nMxa, THRR, and PCS symptom se-
verity. All episodes of data collection were timed, and
the end-of-study feedback was collected from the par-
ticipating patients and healthy controls. All measure-
ments were taken by a clinician and researcher
trained in the use of TCD, finger plethysmography,
CANTAB, SF-36, PCSS, and vestibular assessment.
The inclusion of vestibular metrics is based on anec-
dotal experience of a subset of patients with non-
vestibular dizziness and vertigo (with normal vestibular
function tests and brain imaging) that appear to pose as
a diagnostic and therapeutic corollary to PCS. We aim
to investigate this group of patients as a distinct sub-
group in the next phase of the study.
Equipment and procedure
Demographic information was collected via paper
form, and symptom questionnaires, the SF-36, and
the GOS-E were completed via paper forms. CANTAB
assessment was performed using an iPad Pro (second-
generation 12.9-in, IOS 13.2.1, Apple, USA).
Cerebrovascular profile equipment was mounted on
a three-level cart: one level for the Delica computer sys-
tem (Shenzhen Delica Medical Equipment Company,
Shenzhen, China) with ICM+ software (Cambridge
Enterprise Ltd., Cambridge, UK) installed, one level
for the finger plethysmograph, and one level for storage
of the robotic TCD headband and capnograph
(Fig. 1A).
The Delica Robotic TCD headband was positioned
so the Doppler probes (1.6 pulsed-wave, 81%
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amplitude, 1–2 MHz) were positioned over the trans-
temporal window (Fig. 1B). Field ‘‘scanning’’ is used
to approximate to desirable coordinates and involves
micro-adjustments of the robotic probe in a grid-like
pattern. At each position on the movement grid, the
system assesses signal presence and quality and pro-
duces a color-coded grid map to highlight probe posi-
tions where CBFV is best detectable.40 Anecdotally, the
initial scanning function saves a considerable amount
of time by identifying the general location of the
MCA signal for probe placement. Similarly, the
‘‘search’’ function moves the probe in a spiral pattern,
creating a spiral color-coded map to identify areas of
strong signal.40
Once the probe is placed in this general area, a series
of manual and robotic probe sensor adjustments are
made to refine MCA flow velocity signal recording.
Again, the scanning function guides this refinement
phase. The MCA flow signal is found at a depth of
30–65 mm, with a flow velocity of 55 – 12 cm/sec, con-
tinuous forward flow through systole and diastole, and
a characteristic waveform.41 This is done via the Delica
TCD software interface, which allows activation of ro-
botic functions, changes in probe amplitude, gain, and
depth; and visualization of the Doppler waveform.
Once the signal is achieved, the probes are fastened
in place. The Finapres finger plethysmograph (Finom-
eter Pro, Finapres Medical Systems B.V., Enschede, the
Netherlands) is then placed on the left middle finger
(using the appropriately sized finger cuff), with wire
positioning as per Figure 1B. The hand is kept still
and at heart-level for the entire session.
TCD and Finapres recordings were gathered for 35–
40 min (30 min for nMxa calculation, 5–10 min to ac-
count for artefacts). THRR was then calculated via
the transient hyperaemic response test (THRT)—a se-
ries (two left and two right) of unilateral carotid artery
compressions (5–7 sec). The tests were spaced 1 min
apart to allow for autoregulatory system recovery be-
tween hyperaemic responses. Resting end-tidal CO2
(etCO2) was measured at the time of THRT using a
handheld capnograph (Nellcor N-85 Microstream,
Covidien/Medtronic Minimally Invasive Therapies,
Watford, UK).
FIG. 1. Setup and configuration. (A) Three-level trolley with Delica TCD system and Finapres system
mounted. (B) Delica robotic probes in place, hosted within a bespoke headband. (C) Finapres finger
plethysmograph in situ. TCD, transcranial Doppler.
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Waveforms data from the TCD (Fig. 2A) and Finapres
(Fig. 2B) were recorded using ICM+ installed on the Del-
ica TCD (Fig. 2C) at a rate of 125 Hz. ICM+ is a bespoke
clinical research software for physiological signal collec-
tion, analysis, interpretation, and presentation (https://
icmplus.neurosurg.cam.ac.uk). After data refinement
(artefact removal), nMxa and THRR were calculated by
ICM+ as detailed below (Figs. 3 and 4). nMxa is com-
puted fully automatically, whereas THRR calculations
require marking of the relevant parts of the flow velocity
waveform corresponding to different stages of THRT.
Statistical analysis
Basic descriptive and summary statistics were gener-
ated for the demographic, symptom, quality of life,
and neuropsychological data.
nMxa, calculated using ICM+, is the correlation co-
efficient between slow-wave (0.005–0.05 Hz) changes
FIG. 2. Real-time data collection. (A) Delica TCD interface displaying real-time waveform recording.
(B) Finapres interface recording arterial blood pressure in real time. (C) TCD and Finapres data channeled
into ICM+ software in real time. TCD, transcranial Doppler.
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in ABP and slow-wave changes of CBFV28 calculated
within a moving 5-min window. nMxa values have
been recorded in healthy adults as 0.21 – 0.16 (mean –
standard deviation [SD]),42 with a value of >0.4
thought to be indicative of cerebrovascular autoregula-
tory dysfunction in TBI.28 The THRR represents a
complementary non-invasive CA metric (Fig. 3).32 It
is the ratio of the MCA flow velocity change after
brief ipsilateral carotid artery compression (for 59 sec
causing >30% reduction in systolic flow velocity). On
the restoration of flow, the first systolic peak is ignored
and the next three systolic peaks are assessed and com-
pared with resting flow velocities to calculate the
THRR. A normal response, an indication of preserved
CA, is a flow increase >9% (ratio ‡1.10) of baseline sys-
tolic velocity after compression.32
Results
Participant demographics
In total, 12 participants were initially recruited for this
pilot study—6 healthy controls and 6 patients with TBI.
Two participants were excluded from analysis after un-
successful insonation of the MCA during TCD assess-
ment. Among the 10 included participants, the median
age was 24 years (range 22–63 years, n = 5) for the
healthy controls and 30 years (range 20–48 years,
n = 5) for the patients with TBI sub-groups (Table 1).
The male to female ratio was 7:3. Relevant TBI and
past medical histories of included participants are de-
tailed in Table 1.
Symptom profiles
Median self-reported PCSS scores were 0/126 (range 0–
2) for healthy participants and 6/126 (range 2–41) for
the TBI patient sub-groups (Table 2) with a median du-
ration of symptoms of 4 months (range 1–48). Aggre-
gate scores for each of the 21 PCSS sub-components is
presented in Figure 5. Only one participant (a patient
with TBI) scored any points on the VVAS (score 16/
90) and the vestibular symptom checklist (highlighting
non-specific dizziness, lasting seconds to minutes, ex-
acerbated by standing from sitting, stress, exertion,
and complicated visual environments).
Neuropsychological metrics
and quality-of-life scores
The paired associated learning (PAL) sub-score of the
CANTAB has robust normative data (age, sex, and
level of education matched) available from the CAN-
TAB database. Thus, the percentile score for our candi-
dates relative to this database is presented in Table 2.
Median PAL percentiles were 78 (range 20–85) for
healthy controls and 25 (range 6–84) for the patients
with TBI sub-groups. GOS-E scores for all of the
FIG. 3. ICM+ interface with nMxa calculation. Artefact removal has taken place, representing missing
chunks in data. The correlation coefficient of ABP (first row) and middle cerebral artery flow velocity on the
right (FVR) and left (FVL) is calculated. This is represented by nMXaR and nMXaL, respectively. The last row
displays a correlation line between nMXaR and nMXaL, in this case, R = 0.755. ABP, arterial blood pressure.
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patients with TBI groups fell within the Good Recovery
(Upper or Lower) category (Table 2). Overall SF-36
scores (Table 3) were lower in patients with TBI (me-
dian 66.7%, range 64–78%) than in healthy controls
(median 87.8%, range 87–90%).
Vestibular and cerebrovascular profiles
Abnormalities in vestibular assessment (nystagmus at
rest, horizontal head impulse test, and Fukuda stepping
test) were not elicited in any of the participants
(Table 4).
Two participants (n = 2/12, 16.7%) were excluded
from the study as MCA signals were not clearly identi-
fied and therefore nMxa and THRR were not achiev-
able, leaving five participants in each group for
analysis. In one patient, MCA flow velocity signal
was found and THRT was performed, but a reliable
nMxa value was not obtainable due to patient hyperac-
tivity (related to underlying PCS). nMxa was calculated
for 100% (n = 5/5) of controls and 80% (n = 4/5) of pa-
tients with TBI with MCA recordings (Table 4).
Median nMxa was 0.258 (range 0.06–0.37, n = 5) in
FIG. 4. Transient Hyperaemic Response Ratio (THRR). (A) ICM+ raw data showing a decrease in FVL (flow
velocity in the left MCA). (B) ICM+ data analysis tool is used to calculate THRR value. ABP, arterial blood
pressure; FVR, flow velocity in the right MCA; MCA, middle cerebral artery.
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healthy controls and 0.21 (range 0.02–0.46, n = 4) in
patients with TBI. THRR was only calculated in 50%
of participants, at normocapnic etCO2 levels. Interest-
ingly, THRR values were more favourable in patients
with TBI (median 1.15 [range 1.13–1.16, n = 2] in
healthy controls, 1.18 [range 1.13–1.27, n = 3] in pa-
tients with TBI). The reasons for incomplete THRR
data were as follows: 1) THRT was contraindicated
due to previous retinal ischemic damage in one pa-
tient, 2) data recording was cut short owing to time
limitations on two occasions, and 3) poor compres-
sion quality in two participants (related to difficult
anatomy and a developing learning curve of the re-
search team).
Time taken and feedback
Median time taken for entire data set capture was
127.5 min (range 120–151). In terms of the general di-
vision of this time, setup of the TCD (including identi-
fying and refining MCA flow velocity signal and
initiating recording of Finapres ABP and TCD flow
velocity with ICM+) generally took between 10 and
25 min—depending on the quality and ease of MCA
signal attainment. nMxa measurement requires at
least 30 min of data recording, therefore 35–40 min
were taken to give room for potential signal artefacts.
A set of THRTs followed, taking between 5 and 10 min.
CANTAB assessment took approximately 35 min and
the rest of the assessments (demographics, PCSS,
VVAS, SF-36, GOS-E, and vestibular profile) generally
took between 10 and 15 min.
Additionally, post-study acceptability was scored
by participants from 1 to 5 (1: not acceptable, 2: some-
what acceptable, 3: acceptable, 4: very acceptable, 5: ex-
tremely acceptable). Six participants left feedback, all
rating the study as at least acceptable (n = 2 for an
acceptable score, n = 4 for very acceptable). Positives
aspects of the study, such as ‘‘learning about non-
invasive measures and cerebral blood flow’’ and its ‘‘in-
teractive’’ nature, were highlighted by participants. In
terms of the study challenges, the total ‘‘time-length’’
Table 1. Summary Table Basic Demographics
Participant Age Sex TBI Relevant medical history
Healthy volunteers
1 22 Female None Migraines
2 26 Female None Migraines
3 63 Male None Retinal ischaemia, ex-smoker
4 24 Male None Nil
5 23 Male None Nil
TBI patients
1 30 Male Moderate TBI (7 years ago) with seizures. Medically managed. Last MRI:
encephalomalacia right occipital and parietal lobe (1 year ago).
Nil
2 48 Female Mild TBI with non-depressed skull fracture (8 months ago). Medically
managed. Last MRI: normal.
Nil
3 27 Male Moderate TBI (4 months ago). Medically managed. Last CT: frontal lobe contusion
(4 months ago). Collateral history states increased personality changes, inattention,
hyperactivity and emotional lability since TBI. Patient does not subjectively
offer these symptoms although they were obvious during the observation/encounter.
Nil
4 33 Male Mild/moderate TBI with seizures (4 weeks ago). Medically managed. Last CT:
left frontal and parietal contusions (2 weeks ago).
Alcoholism, active smoker
5 20 Male Severe TBI (4 months ago). Medically managed. Last MRI: DAI, bifrontal
contusions (2 months ago).
Ex-smoker
CT, computed tomography; DAI, diffuse axonal injury; MRI, magnetic resonance imaging; TBI, traumatic brain injury.








1 2 0 Normal NA 79
2 0 0 Normal NA 78
3 0 0 Normal NA 20
4 0 0 Normal NA 85
5 0 0 Normal NA 44
TBI patients
1 13 0 Normal Lower GR 84
2 41 16 Normal Lower GR 6
3 6 0 Normal Upper GR 10
4 4 0 Normal Upper GR 49
5 2 0 Normal Lower GR 25
Normative data (age, sex, and level of education matched) were avail-
able from the CANTAB database for the PAL test. Therefore, the percen-
tile score for our candidates relative to this database is presented for
illustrative purposes. Results for other tests within the TBI test battery
can be analyzed in the context of the normative data set that will be gen-
erated by this project.
CANTAB, Cambridge Neuropsychological Test Automated Battery;
GOS-E, Glasgow Outcome Scale Extended; GR, good recovery; NA, not
applicable; PAL, Paired Associated Learning; PCSS, Post-Concussive Syn-
drome Symptom Scale; VVAS, Vestibular Visual Analogue Scale.
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taken for measurements was raised, as well as ‘‘mild
temporal pain’’ after prolonged temporal TCD probe
application.
In regard to operator (D.Z.K.) feedback based on an-
ecdotal experience, some technical points were noted.
First, the Delica TCD probe arms (sensor probe at
the head, wire at tail) are mobile within the headband
construct and are secured into place by a screw system
(Fig. 6). This screw is for fastening the base of the probe
to the plastic headband frame. However, upon tighten-
ing, there is a degree of movement of the probe sensor
(head of the probe arm) inwards toward the partici-
pant’s head. Thus, at certain angles, the screws would
have to be tightened to a maximal tightness to keep
the probe arm in place for a prolonged period in an
awake participant. This tightening can cause the sensor
probe to press on the participant’s temples, which, after
some minutes of application, may cause pain at the
temple or referred pain down the jaw. The close
probe-skin contact may also displace the applied ultra-
sonic gel and interrupt MCA signal quality.
Similarly, the placement of the wire at the base of
the probe arm means that when the probe’s head (with
the sensor probe) is angled inferiorly and the tail (with
FIG. 5. Post-Concussion Symptom Scale mean subcomponent scores for the TBI patient cohort. TBI,
traumatic brain injury.

















1 100% 100% 100% 70% 88% 100% 90% 90% 50%
2 100% 100% 100% 80% 84% 100% 100% 100% 50%
3 NR NR NR NR NR NR NR NR NR
4 100% 100% 100% 85% 88% 100% 100% 95% 25%
5 100% 100% 100% 75% 64% 100% 100% 95% 50%
TBI patients
1 55% 50% 100% 80% 68% 87.5% 0% 85% 75%
2 60% 100% 100% 20% 68% 75% 57.5% 70% 25%
3 100% 100% 66.7% 55% 44% 100% 77.5% 60% 100%
4 95% 0% 100% 95% 68% 50% 80% 70% 50%
5 75% 0% 33% 65% 84% 75% 100% 80% 75%
Higher scores represent a more favorable health state.
SF-36, Short-Form 36 Health Survey; NR, not recorded; TBI, traumatic brain injury.
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the probe wire) is therefore superiorly placed—gravity
pulls the heavy wire down and displaces the probe sensor
at the head. Ways to mitigate this include providing
cushioning support to the wiring/probe trail (to offload
the weight across the probe arm) or by further tightening
the screws (but potentially causing pain for the partici-
pant). Further development of the screw mechanism
and offloading of wire traction would provide a more sta-
ble and comfortable device for prolonged usage.
Finally, in terms of software challenges, the ‘‘track’’
function was difficult to use. This function is for follow-
ing and maintaining the MCA signal by automatically
adjusting the probe position and ultrasound wave
properties in response to minor movements of the
headband. However, we found that even when a
high-quality MCA signal was found, when the tracking
was engaged, any significant movement of the head-
band would trigger the system to adjust the probe/
waves but focus on a random vessel signal that clearly
was not the MCA. Other reports echo this difficulty
with this robotic TCD system.40 Refinement of this
function would be particularly useful for awake partic-
ipants who will naturally move to a certain degree dur-
ing the examination and may slightly dislodge the
headband. We have been informed by the manufac-
turer that significant improvements have been made
recently to address these problems, but we have not
yet had a chance to verify those claims.
Discussion
This pilot study has demonstrated a reproducible as-
sessment of PCS symptoms and non-invasive measures
of CA in five controls and five patients with TBI. The
protocol has been applied in a real-world setting in
an acceptable, feasible, and effective manner.
First, we developed a protocol and workstream
with 100% (n = 6) perceived acceptability rates among
both patients and healthy controls (via participant
feedback)—although one of the patients was unable
to tolerate staying still for the entire nMxa measure-
ment. Study integration into ongoing neurotrauma clin-
ics made recruitment of the target population feasible
and convenient (for both the participants and research-
ers). Although our study requires a considerable time
commitment (median 127.5 min), much of this time
could fill periods patients would otherwise spend wait-
ing at clinic appointments. We anticipate that with the
refinement of our protocol, questionnaire assessments
could be carried out on online platforms at the partici-
pant’s convenience and the TCD monitoring period
could be shortened.
Additionally, in developing this workstream, we
have: established a dedicated CA trolley setup, li-
censed relevant software (ICM+, CANTAB), and de-
veloped local expertise in administering data
instruments. This protocol captures a broad and
multi-faceted data set in real time and therefore is
Table 4. Summary of Vestibular and Cerebrovascular Profile Recorded per Participant
Participant Vestibular maneuvers nMxa THRR
Healthy volunteers








3 Normal 0.12 right
0.15 left
Contraindicated
4 Normal 0.31 right
0.37 left
Time-limited encounter
5 Normal 0.06 right
0.16 left
Poor compression quality/difficult anatomy
TBI patients
1 Normal 0.46 right
0.44 left
Time-limited encounter
2 Normal 0.14 right
0.08 left
Poor compression quality/difficult anatomy
3 Normal Not possible (hyperactivity) 1.19 right
1.14 left








Vestibular maneuvers consisted of nystagmus at rest, horizontal head impulse test, and Fukuda stepping test.
TBI, traumatic brain injury; THRR, transient hyperaemic response ratio.
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readily available to treating clinicians. It is effective—
in most participants, a combination of TCD and
Finapres monitoring (for nMxa or THRR) was possi-
ble. In two participants (2/12, 16.7%) an MCA signal
was not established bilaterally: one was an elderly fe-
male (age and female sex are associated temporal bone
thickening) and the other was a young male who had a
healed convexity skull fracture across the insonation
site. This is in line with rates of temporal window fail-
ure, reported as generally between 5 and 20%.43,44 We
FIG. 6. Robotic TCD headband constituents. (A) The probe arm is denoted by ‘‘1,’’ with the sensor at the
head of the probe arm denoted by ‘‘2.’’ (B) The probe arm is mobile within the frame of the headband (‘‘3’’)
and fastened in the desired position with a screw (‘‘4’’). (C) An anterior-posterior view of the construct with
the probe arms on the left and right. (D) An oblique view of the construct, with the output wire (‘‘6’’) from
the probe arm at its tail. This loops upwards and then backwards and may exert an anti-clockwise rotatory
force on the probe arm. The blue arrows represent a tendency for the probe arms and sensor probes to
apply pressure inwards toward the participant’s temples when the securing screw is significantly tightened.
Figure adapted with author permission from Zeiler and Smielewski.40 TCD, transcranial Doppler.
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anticipate that this would only be improved with fur-
ther refinements in study technique and planning.
Findings in the context of literature
The lack of a mechanistic understanding of PCS has
made the identification of suitable biomarkers and spe-
cific treatments for PCS after mTBI difficult. Establish-
ing a PCS biomarker or set of biomarkers will allow
objective diagnosis, prognostication, and rigorous pa-
tient follow-up/recovery, and will facilitate methodo-
logical research.45,46 These biomarkers should ideally
be non-invasive and easily assessed.
The benefits of nMxa and THRR lie in their non-
invasive nature, with TCD central to both. Many
groups have described the use of TCD to assess cerebral
hemodynamics in patients with mTBI and PCS. Specif-
ically, post-TBI CRx dysfunction (measured via assess-
ing CBFV changes during CO2 challenges) has been
found after mTBI in athletes and is associated with
the presence of PCS symptoms, particularly headache
and cognitive symptoms.15,17 Another non-invasive
method employed in patients with mTBI is advanced
MRI, which has reiterated the disruption of cerebral
hemodynamics as a prominent and common feature
in PCS patients. ASL has been used to find differences
in CBF patterns in pediatric patients 40 days follow-
ing mTBI.17 Patient without PCS symptoms showed
a global decrease in CBF, as compared with healthy
controls, whereas those with PCS exhibited a global
increase in CBF.17 Longitudinal ASL MRI analysis
of concussed athletes over 1 month has suggested
decreased regional blood flow in the right superior
temporal sulcus (transient) and right dorsal mid-
insular cortex (persistent at 1 month) when compared
with non-concussed athletes.20 However, MRI imag-
ing is costly, time-consuming, and difficult to apply
in a wider population (e.g., metal implants and
claustrophobia).
Although TCD is inexpensive and its sensitivity and
specificity for monitoring of CBF is excellent, it is typ-
ically technically limited to short recording durations
as minor movements of carefully placed probes may in-
terrupt data collection.47 Semi-automated (robotic)
TCD has been developed to facilitate extended, unin-
terrupted recordings using automated correction algo-
rithms and flow velocity sampling methods to maintain
optimum probe positioning.47 Robotic TCD allows
more consistent and reproducible assessment of TCD
metrics simplifying what was previously a highly
operator-dependent intervention. As this technology
becomes more autonomous and more integrated with
plethysmograph and processing software, it may
allow non-specialists to carry out the analysis in any
outpatient or inpatient setting.
Limitations and strengths
This pilot methodology has its limitations. First, even
with the robotic probe assistance, there is a consider-
able learning curve for the correct use of TCD. Further,
a consistent application of a suitable compression of
the carotid arteries for THRT assessment requires
some practice. With current mathematical modeling,
a reliable nMxa is calculated using 30 min of recording
after artefact removal and signal correction, meaning a
minimum of 35–40 min of recording is required. Like
with other methods that require a longer time to ac-
quire signal, this makes such a protocol unsuitable
for a proportion of patients. One participant, as part
of his PCS, suffered from hyperactivity, difficulty con-
centrating, and early irritability, and resultantly, found
the long periods of concentration required for the study
difficult. Exploration of other indices of CA that can be
performed over a shorter period is important to im-
prove the feasibility and compliance of these tech-
niques in contemporaneous practice.
Although the THRT can be performed over a short
period of time, anecdotally, it is difficult in participants
with certain anatomical characteristics (elevated body
mass index [BMI], short necks) and sometimes uncom-
fortable for awake participants. Although there were
slight differences between median nMxa and THRT
values between sub-groups, our sample size is not
intended to draw any conclusions about the relation-
ship between nMxa and PCS. However, this methodol-
ogy can be scaled to a larger patient population. Based
on a mean nMxa or Mx in healthy adults of 0.21 (SD:
0.16) and abnormal values of Mx considered as
>0.4,42,48 it is estimated that at least 100 participants
distributed evenly across study groups are required to
detect a difference with 90% power at a significance
level of 5%.
Conclusion
This pilot study has demonstrated a reproducible as-
sessment of PCS symptoms and non-invasive measures
of CA in five controls and five patients with TBI in a
real-world setting. By scaling this methodology into a
larger study, we hope to test whether changes in CA
are correlated with symptomatic PCS in patients with
a history of TBI.
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